Pattern-mixture-type estimation and testing of neuroblastoma treatment regimes (Q2320951): Difference between revisions

@@ Property / cites work @@
+Supremum weighted log-rank test and sample size for comparing two-stage adaptive treatment strategies
+Normal rank
@@ Property / cites work @@
+Q3999494
@@ Property / cites work: Q3999494 / rank @@
+Normal rank
@@ Property / cites work @@
+A Weighted Risk Set Estimator for Survival Distributions in Two-Stage Randomization Designs with Censored Survival Data
+Normal rank
@@ Property / cites work @@
+Survival analysis. Techniques for censored and truncated data.
+Normal rank
@@ Property / cites work @@
+Pattern-Mixture Models for Multivariate Incomplete Data
+Normal rank
@@ Property / cites work @@
+Cox Regression Methods for Two-Stage Randomization Designs
+Normal rank
@@ Property / cites work @@
+Estimation of Survival Distributions of Treatment Policies in Two-Stage Randomization Designs in Clinical Trials
+Normal rank
@@ Property / cites work @@
+Optimal Dynamic Treatment Regimes
@@ Property / cites work: Optimal Dynamic Treatment Regimes / rank @@
+Normal rank
@@ Property / cites work @@
+Screening Experiments for Developing Dynamic Treatment Regimes
+Normal rank
@@ Property / cites work @@
+Marginal Mean Models for Dynamic Regimes
@@ Property / cites work: Marginal Mean Models for Dynamic Regimes / rank @@
+Normal rank
@@ Property / cites work @@
+A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
+Normal rank
@@ Property / cites work @@
+Addendum to ``A new approach to causal inference in mortality studies with a sustained exposure period. Application to control of the healthy worker survivor effect''
+Normal rank
@@ Property / cites work @@
+Optimal Estimator for the Survival Distribution and Related Quantities for Treatment Policies in Two‐Stage Randomization Designs in Clinical Trials
+Normal rank
@@ Property / cites work @@
+Semiparametric efficient estimation of survival distributions in two-stage randomisation designs in clinical trials with censored data
+Normal rank